CAR as Booster to Launch Allogeneic Transplantation in Refractory Leukemia
New England Journal of Medicine · 2024
DOI: 10.1056/nejme2403003 ↗Kurz gefasst
Editorial in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von Didier Blaise. Beteiligte Einrichtung: From the Department of Hematology, Transplant and Cellular Immunotherapy Program, Institut Paoli Calmettes, Management Sport Cancer laboratory, Aix-M…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Immunotherapy, Adoptive, Leukemia, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Hematology, Transplant and Cellular Immunotherapy Program, Institut Paoli Calmettes, Management Sport Cancer laboratory, Aix-Marseille University, Marseille, France.
Zitieren
APA
Blaise, D. (2024). CAR as Booster to Launch Allogeneic Transplantation in Refractory Leukemia. New England Journal of Medicine. https://doi.org/10.1056/nejme2403003
Vancouver
Blaise D. CAR as Booster to Launch Allogeneic Transplantation in Refractory Leukemia. New England Journal of Medicine. 2024. doi:10.1056/nejme2403003
BibTeX
@article{Blaise2024,
author = {Blaise, Didier},
title = {CAR as Booster to Launch Allogeneic Transplantation in Refractory Leukemia},
journal = {New England Journal of Medicine},
year = {2024},
doi = {10.1056/nejme2403003}
}
EUVIMED